Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
193
datasets available to search
ShareScore release 0.9.0
Dataset results
193 results for “CD20”
CD20 positive CD8 T cells are a unique and transcriptionally-distinct subset of T cells with distinct transmigration properties
GEO Series GSE184833. Homo sapiens. 6 samples. Type: Expression profiling by high throughput sequencing.
Gene expression analysis between CD20- CD138- and CD20+ CD138+ subpopulations using sorted MWCL-1
GEO Series GSE73756. Homo sapiens. 4 samples. Type: Expression profiling by array.
SRC family kinases are involved in the regulation of CD20
GEO Series GSE50929. Homo sapiens. 8 samples. Type: Expression profiling by array.
CD20 is a mammalian odorant receptor expressed in a subset of olfactory sensory neurons that mediates innate avoidance of predators
GEO Series GSE240378. Mus musculus. 9 samples. Type: Expression profiling by high throughput sequencing.
Transcriptomic data of B-cell lymphoma bearing mice treated with anti-CD20/-CD27 mAb therapy
GEO Series GSE97037. Mus musculus. 4 samples. Type: Expression profiling by high throughput sequencing.
B cell-extrinsic and intrinsic factors linked to early immune repletion after anti-CD20 therapy in patients with Multiple Sclerosis of African Ancestry
GEO Series GSE297571. Homo sapiens. 41 samples. Type: Methylation profiling by array.
Polymorphisms at Distinct Genetic Loci Affect Response to Anti-CD20 Monoclonal Antibody Therapies
ClinicalTrials.gov study NCT02694913. IPD Sharing: NO. Countries: 1. Publications: 0.
Fully Human Bispecific Anti-CD20, Anti-CD19 CAR T Cells for Patients With Relapsed and/or Refractory B Cell Malignancies
ClinicalTrials.gov study NCT07335328. IPD Sharing: NO. Countries: 1. Publications: 0.
The Clinical Study of CD20 CAR-T Cells in Patients With Relapsed and Refractory B Cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT04169932. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of EX103 in Subjects with Relapsed/Refractory CD20-Positive Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT06021678. IPD Sharing: Not stated. Countries: 1. Publications: 0.
R-CHOP Alone vs. R-CHOP Plus Radiotherapy for Localized CD20+ DLBCL
ClinicalTrials.gov study NCT02054559. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of Anti-CD20/CD30 CAR-T Cells in Subjects with Relapsed/Refractory Lymphoma
ClinicalTrials.gov study NCT06532643. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Pharmacokinetic Study of IMM0306 in Patients With Refractory or Relapsed CD20-positive B-cell Non-Hodgkin's Lymphoma (B-NHL)
ClinicalTrials.gov study NCT04746131. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL
ClinicalTrials.gov study NCT02393157. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Rituximab Plus CAMPATH in Patients With Relapsed/Refractory Low-Grade or Follicular, CD20-positive, B-cell NHL
ClinicalTrials.gov study NCT00077961. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Atezolizumab in Combination With an Immunotherapy Agent Investigated With or Without Anti-Cd20 Therapy in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT03369964. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Assess Changes in Immunoglobulins in Patients With Relapsing Multiple Sclerosis Treated With Anti-CD20 Therapies
ClinicalTrials.gov study NCT06526000. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CC-486, Lenalidomide, and Obinutuzumab for the Treatment of Recurrent or Refractory CD20 Positive B-cell Lymphoma
ClinicalTrials.gov study NCT04578600. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Trial of TQB2825 in Subjects With CD20 Positive Hematological Tumors
ClinicalTrials.gov study NCT05489276. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Recombinant Human-Mouse Chimeric Anti-CD20 Monoclonal Antibody to Treat Non-hodgkin's Lymphoma
ClinicalTrials.gov study NCT01459887. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.